Type of Spiritual Experience
A description of the experience
Adalimumab, trade names Humira ("human monoclonal antibody in rheumatoid arthritis") and Exemptia.
Is marketed as HUMIRA - "Human Monoclonal Antibody in Rheumatoid Arthritis". It was the third TNF inhibitor, after infliximab and etanercept, to be approved in the United States. Like infliximab and etanercept, adalimumab binds to TNFα, preventing it from activating TNF receptors; adalimumab was constructed from a fully human monoclonal antibody, while infliximab is a mouse-human chimeric antibody and etanercept is a TNF receptor-IgG fusion protein.
It is used in the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, moderate to severe chronic psoriasis and juvenile idiopathic arthritis.
On Dec, 26, 2016 358,739 people reported to have side effects when taking Humira. Among them, 165 people (0.05%) have Hallucination
On Dec, 28, 2016 358,739 people reported to have side effects when taking Humira. Among them, 31 people (0.01%) have Hallucination, Auditory
Time on Humira when people have Hallucination :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years|
Gender of people who have Hallucination when taking Humira :
Age of people who have Hallucination when taking Humira :
On Dec, 21, 2016 358,739 people reported to have side effects when taking Humira. Among them, 2,790 people (0.78%) have Death
The source of the experienceeHealthme
Concepts, symbols and science items
Activities and commonsteps